等待开盘 10-01 09:30:00 美东时间
+0.330
+1.18%
最高股息率超15%!默沙东、惠普、必和必拓等180多家美股公司即将派息;投资者若想赚取股息,可趁未除净适时部署,一文速览派息名单>>
09-01 19:16
JP Morgan analyst Jeremy Tonet downgrades South Bow (NYSE:SOBO) from Neutral to Underweight and announces $27 price target.
08-21 20:32
RBC Capital analyst Maurice Choy maintains South Bow (TSX:SOBO) with a Outperform and raises the price target from C$38 to C$39.
08-09 02:39
South Bow Corporation (TSX:SOBO:CA) declares CAD 0.50/share quarterly dividend, Payable Oct. 15; for shareholders of record Sept. 29; ex-div Sept. 29. See SOBO:CA Dividend Scorecard, Yield Chart, & Di...
08-07 06:19
South Bow (NYSE:SOBO) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.33 by 27.66 percent. This is a 23.53 percent increase over earnings of $0.34 per share from the same
08-07 06:02
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
South Bow Corp. announced the extension of the expiration date for exchange offers relating to certain outstanding notes. The Canadian Exchange Offer for 7.625% and 7.500% Junior Subordinated Notes due 2055, and the U.S. Exchange Offer for Senior Notes due 2027, 2029, 2034, and 2054, have been extended from Aug. 4, 2025, to Aug. 6, 2025. The prospectuses for both offers have been filed with regulatory bodies, and South Bow recommends holders revi...
07-17 21:00
South Bow Corp. will release its second-quarter 2025 financial and operational results after markets close on Aug. 6, 2025. A conference call and webcast to discuss the results will be held on Aug. 7, 2025, at 8 a.m. MT (10 a.m. ET). Participants can register in advance to receive a unique PIN for access. The replay will be available on the company’s investor website following the event. Forward-looking statements in this release are subject to r...
07-10 23:42
潜在涨幅300.0%!HC Wainwright & Co.:Armata Pharmaceuticals获机构升目标价至9美元,维持"买入"评级
05-21 16:44
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1131517965561573377.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.:维持Armata Pharmaceuticals(ARMP)"买入"评级,目标价从7美元升至9美元</p> <p>• 瑞银:维持爱芬奇(ANF)"买入"评级,目标价从115美
05-20 09:28